Iron deficiency protects against severe plasmodium falciparum malaria and death in young children

Clinical Infectious Diseases

Volumn 54, Issue 8, 2012, Pages 1137-1144

  Gwamaka, Moses ^a,b,c   Kurtis, Jonathan D ^d,e   Sorensen, Bess E ^a,b   Holte, Sarah ^f   Morrison, Robert ^a,b   Mutabingwa, Theonest K ^a,b,g   Fried, Michal ^a,b,h,i   Duffy, Patrick E ^a,b,h,i  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b Muheza Designated District Hospital   (Tanzania)

^c SOKOINE UNIVERSITY OF AGRICULTURE   (Tanzania)

^d RHODE ISLAND HOSPITAL   (United States)

^e BROWN UNIVERSITY   (United States)

^f USA   (United States)

^g NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SMEAR; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; IRON DEFICIENCY; IRON INTAKE; MALARIA FALCIPARUM; MALE; NEWBORN; PARASITEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL;

FEMALE; HUMANS; IRON; MALARIA, FALCIPARUM; MALE;

EID: 84859024250     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis010     Document Type: Article

References (43)

1. Oski FA, Honig AS, Helu B, Howanitz P. Effect of iron therapy on behavior performance in nonanemic, iron-deficient infants. Pediatrics 1983; 71:877-80.
2. Sheard NF. Iron deficiency and infant development. Nutr Rev 1994; 52:137-40.
3. Sazawal S, Black RE, Ramsan M, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006; 367:133-43.
4. Oppenheimer SJ, Gibson FD, Macfarlane SB, et al. Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua New Guinea. Trans R Soc Trop Med Hyg 1986; 80:603-12.
5. Smith AW, Hendrickse RG, Harrison C, Hayes RJ, Greenwood BM. The effects on malaria of treatment of iron-deficiency anaemia with oral iron in Gambian children. Ann Trop Paediatr 1989; 9:17-23.
6. Iannotti LL, Tielsch JM, Black MM, Black RE. Iron supplementation in early childhood: health benefits and risks. Am J Clin Nutr 2006; 84:1261-76.
7. Mebrahtu T, Stoltzfus RJ, Chwaya HM, et al. Low-dose daily iron supplementation for 12 months does not increase the prevalence of malarial infection or density of parasites in young Zanzibari children. J Nutr 2004; 134:3037-41.
8. Menendez C, Kahigwa E, Hirt R, et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997; 350:844-50.
9. Kabyemela ER, Fried M, Kurtis JD, Mutabingwa TK, Duffy PE. Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. J Infect Dis 2008; 198:163-6.
10. Nyakeriga AM, Troye-Blomberg M, Dorfman JR, et al. Iron deficiency and malaria among children living on the coast of Kenya. J Infect Dis 2004; 190:439-47.
11. Mutabingwa TK, Bolla MC, Li JL, et al. Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med 2005; 2:e407.
12. Coutinho HM, McGarvey ST, Acosta LP, et al. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis 2005; 192:528-36.
13. WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1):S1-90.
14. Leenstra T, Coutinho HM, Acosta LP, et al. Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation. Infect Immun 2006; 74:6398-407.
15. Cook JD, Skikne BS. Iron deficiency: definition and diagnosis. J Intern Med 1989; 226:349-55.
16. Kuvibidila S, Yu LC, Ode DL, Warrier RP, Mbele V. Assessment of iron status of Zairean women of childbearing age by serum transferrin receptor. Am J Clin Nutr 1994; 60:603-9.
17. van den Broek NR, Letsky EA, White SA, Shenkin A. Iron status in pregnant women: which measurements are valid? Br J Haematol 1998; 103:817-24.
18. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89:1052-7.
19. Phiri KS, Calis JC, Siyasiya A, Bates I, Brabin B, van Hensbroek MB. New cut-off values for ferritin and soluble transferrin receptor for the assessment of iron deficiency in children in a high infection pressure area. J Clin Pathol 2009; 62:1103-6.
20. Fleming TR, Harrington D. Counting processes, and survival analysis. New York, NY: John Wiley & Sons, 1991.
21. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York, NY: Springer-Verlag, 2000.
22. Salvan A, Thomaseth K, Bortot P, Sartori N. Use of a toxicokinetic model in the analysis of cancer mortality in relation to the estimated absorbed dose of dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD). Sci Total Environ 2001; 274:21-35.
23. Hay G, Sandstad B, Whitelaw A, Borch-Iohnsen B. Iron status in a group of Norwegian children aged 6-24 months. Acta Paediatr 2004; 93:592-8.
24. Mamiro PS, Kolsteren P, Roberfroid D, Tatala S, Opsomer AS, Van Camp JH. Feeding practices and factors contributing to wasting, stunting, and iron-deficiency anaemia among 3-23-month old children in Kilosa district, rural Tanzania. J Health Popul Nutr 2005; 23:222-30.
25. Iolascon A, De Falco L, Beaumont C. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica 2009; 94:395-408.
26. Aponte JJ, Menendez C, Schellenberg D, et al. Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med 2007; 4:e242.
27. Smith AW, Hendrickse RG, Harrison C, Hayes RJ, Greenwood BM. Iron-deficiency anaemia and its response to oral iron: report of a study in rural Gambian children treated at home by their mothers. Ann Trop Paediatr 1989; 9:6-16.
28. Ojukwu JU, Okebe JU, Yahav D, Paul M. Oral iron supplementation for preventing or treating anaemia among children in malaria-endemic areas. Cochrane Database Syst Rev 2009; (3):CD006589.
29. Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response-lessons from malaria and human immunodeficiency virus. Ann Clin Biochem 2008; 45:18-32.
30. WHO. Assessing the iron status of populations: report of a Joint World Health Organization/Centers for Disease Control and Prevention technical consultation on the assessment of iron status at the population level. Geneva, Switzerland: WHO Press; 2004: 6-8.
31. Kung'u JK, Wright VJ, Haji HJ, et al. Adjusting for the acute phase response is essential to interpret iron status indicators among young Zanzibari children prone to chronic malaria and helminth infections. J Nutr 2009; 139:2124-31.
32. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-54.
33. Pelletier DL, Frongillo EA Jr, Habicht JP. Epidemiologic evidence for a potentiating effect of malnutrition on child mortality. Am J Public Health 1993; 83:1130-3.
34. Sanchez-Lopez R, Haldar K. A transferrin-independent iron uptake activity in Plasmodium falciparum-infected and uninfected erythrocytes. Mol Biochem Parasitol 1992; 55:9-20.
35. Hershko C, Peto TE. Deferoxamine inhibition of malaria is independent of host iron status. J Exp Med 1988; 168:375-87.
36. Fritsche G, Larcher C, Schennach H, Weiss G. Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection. J Infect Dis 2001; 183:1388-94.
37. Weiss G, Thuma PE, Mabeza G, Werner ER, Herold M, Gordeuk VR. Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria. J Infect Dis 1997; 175:226-30.
38. Gordeuk V, Thuma P, Brittenham G, et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 1992; 327:1473-7.
39. Thuma PE, Mabeza GF, Biemba G, et al. Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans R Soc Trop Med Hyg 1998; 92:214-8.
40. Klotz FW, Scheller LF, Seguin MC, et al. Co-localization of induciblenitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J Immunol 1995; 154:3391-5.
41. Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK. The structure of malaria pigment beta-haematin. Nature 2000; 404:307-10.
42. Rettmer RL, Carlson TH, Origenes ML, Jack RM, Labb RF. Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency. Pediatrics 1999; 104:e37.
43. Iyer JK, Shi L, Shankar AH, Sullivan DJ Jr. Zinc protoporphyrin IX binds heme crystals to inhibit the process of crystallization in Plasmodium falciparum. Mol Med 2003; 9:175-82.